PATEL: Objective Measurement of Cognitive Impairment in Breast Cancer Survivors who received Adjuvant Chemotherapy and Report Cognitive Decline

Objective Measurement of Cognitive Impairment in Breast Cancer Survivors who received Adjuvant Chemotherapy and Report Cognitive Decline

Patel Chemo Brain
Cancer
Mehul Patel, MD
Enrolling
Rachel O'Loughlin, RN
(585) 747-4555
(585) 922 - 5665